All 1 tracked stories fall under one category: pharma. Anne Lockwood is most often covered alongside Caroline Waldron, which appears in 1 of these 1 story. Anne Lockwood appears in 1 tracked Biotech story from February 26, 2026. The tracked stories average 4 original sources each.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Anne Lockwood
All 1 tracked stories fall under one category: pharma. Anne Lockwood is most often covered alongside Caroline Waldron, which appears in 1 of these 1 story. Anne Lockwood appears in 1 tracked Biotech story from February 26, 2026. The tracked stories average 4 original sources each.
Stories tracked
1
Sources per story
4
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Anne Lockwood. Shared-story counts are live from our verified record — not editorial picks.
Genetic Signatures (ASX:GSS) reported a modest revenue increase for H1 FY26 but warned that its current cash burn rate is unsustainable, prompting immediate board intervention. Meanwhile, the broader ASX landscape saw significant consolidation as ClearView Wealth (ASX:CVW) entered a definitive acquisition agreement with Zurich following a period of strong profitability.
Anne Lockwood is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.